K223602

Substantially Equivalent

Traumatic brain injury (TBI) test

Applicant: Abbott Laboratories
Product code: QAT
Advisory panel: Immunology
Date received: 2022-12-02
Decision date: 2023-03-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.